期刊文献+

瘦素对帕金森病患者神经功能的影响 被引量:2

Effect of leptin on nerve function in patient with Parkinson disease
下载PDF
导出
摘要 目的探讨瘦素对帕金森病(Parkinson disease,PD)患者神经功能的影响及临床意义。方法选取2013年10月~2014年12月于河北大学附属医院神经内科已确诊为帕金森病的患者68例,采用随机数字表法将患者随机分为实验组和对照组,对照组(n=34)行常规治疗,实验组(n=34)在常规治疗的基础上联合应用瘦素,连续治疗12周。治疗前后对2组患者分别进行日常生活能力量表(activity of daily living scale,ADL)及简易智力状态检查量表(mini-mental state examination,MMSE)评分,并分析其临床意义。结果治疗后实验组的ADL评分明显低于对照组(P<0.05),MMSE评分明显高于对照组(P<0.05)。2组患者发生的不良反应均较轻微。结论瘦素治疗帕金森病具有较好的疗效,能够明显改善帕金森病患者的神经功能,不良反应轻微。 Objective To investigate effect of leptin on nerve function in patient with Parkinson disease. Methods 68 cases patients with PD were selected and randomly divided into two groups,according to random number table,from October 2013 to December 2014 in the hospital. 34 cases in control group were treated with conventional therapy,and 34 cases in experimental group were treated with leptin,with a consecutive treatment of twelve weeks. The score of activity of daily living scale( ADL) and mini-mental state examination( MMSE) were analyzed pre and post-treatment.Results After treatment,the ADL score of experimental group was significantly lower than that of control group( P < 0. 05),MMSE score of experimental group was significantly higher than that of control group( P < 0. 05). The adverse reactions in both groups were minor. Conclusion Leptin has good curative effect in treatment of Parkinson disease,and could significantly improve the neurological function of patients,with mild adverse reactions.
作者 陈立英 姜晔
出处 《中国生化药物杂志》 CAS 2015年第8期152-153,157,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 瘦素 帕金森病 神经功能 leptin Parkinson disease nerve function
  • 相关文献

参考文献9

二级参考文献62

  • 1陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:102
  • 2Tang B Xiong H Sun P Zhang Y Wang D Hu Z Zhu Z Ma H Pan Q Xia JH Xia K Zhang Z.Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease[J].中国生物学文摘,2006,20(8):16-16. 被引量:30
  • 3温洪波,张振馨,罗毅,陈生弟,蒋雨平,张小英,孙相如,王新德,姚晨.普拉克索治疗帕金森病的多中心、随机、双盲、溴隐亭对照临床疗效和安全性研究[J].中华神经科杂志,2006,39(9):604-608. 被引量:63
  • 4王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 5Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson' s disease. N Engl J Med, 1993, 328 : 176-183.
  • 6Hauser RA, Lew MF, Hurtig HI, et al. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson' s disease. Mov Disord, 2008, 24:562-571.
  • 7Bonuccelli U, Pavese N. Role of dopamine agonists in Parkinson' s disease : an update. Expert Rev Neurother, 2007, 7 : 1391-1399.
  • 8Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 2002, 59 : 1541-1550.
  • 9Albin RL, Frey KA. Initial agonist treatment of Parkinson disease : a critique. Neurology, 2003, 60 : 390-394.
  • 10Olanow W, Schapira AH, Rascol O. Continuous dopamine- receptor stimulation in early Parkinson' s disease. Trends Neurosci, 2000, 23 ( 10 Suppl) : Sl17-126.

共引文献465

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部